Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies

Virology

Volumn 361, Issue 2, 2007, Pages 283-293

  Nelson, Christian D S ^a   Palermo, Laura M ^a   Hafenstein, Susan L ^b   Parrish, Colin R ^a  

^a Animal Health Diagnostic Center   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Antibody; Canine parvovirus; Feline panleukopenia virus; Immunity; Neutralization

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; TRANSFERRIN RECEPTOR;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; CORRELATION ANALYSIS; FELINE PANLEUKOPENIA VIRUS; IN VITRO STUDY; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS INFECTION; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; ANTIGENS, VIRAL; BINDING, COMPETITIVE; CAPSID; CELL LINE; EPITOPES; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; LEUKEMIA VIRUS, FELINE; NEUTRALIZATION TESTS; PARVOVIRUS, CANINE; PROTEIN BINDING; RECEPTORS, TRANSFERRIN;

CANINE PARVOVIRUS; FELIDAE; FELINE PANLEUKOPENIA VIRUS; MIRIDAE; PARVOVIRUS;

EID: 34147149773     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.11.032     Document Type: Article

References (92)

1. Agbandje M., McKenna R., Rossmann M.G., Strassheim M.L., and Parrish C.R. Structure determination of feline panleukopenia virus empty particles. Proteins 16 4 (1993) 155-171
2. Bailey J., Blankson J.N., Wind-Rotolo M., and Siliciano R.F. Mechanisms of HIV-1 escape from immune responses and antiretroviral drugs. Curr. Opin. Immunol. 16 4 (2004) 470-476
3. Bruemmer A., Scholari F., Lopez-Ferber M., Conway J.F., and Hewat E.A. Structure of an insect parvovirus (Junonia coenia Densovirus) determined by cryo-electron microscopy. J. Mol. Biol. 347 4 (2005) 791-801
4. Buonavoglia D., Cavalli A., Pratelli A., Martella V., Greco G., Tempesta M., and Buonavoglia C. Antigenic analysis of canine parvovirus strains isolated in Italy. New Microbiol. 23 1 (2000) 93-96
5. Buonavoglia C., Martella V., Pratelli A., Tempesta M., Cavalli A., Buonavoglia D., Bozzo G., Elia G., Decaro N., and Carmichael L. Evidence for evolution of canine parvovirus type 2 in Italy. J. Gen. Virol. 82 12 (2001) 3021-3025
6. Burton D.R. Antibodies, viruses and vaccines. Nat. Rev., Immunol. 2 9 (2002) 706-713
7. Casal J.I., Langeveld J.P., Cortes E., Schaaper W.W., van Dijk E., Vela C., Kamstrup S., and Meloen R.H. Peptide vaccine against canine parvovirus: identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence. J. Virol. 69 11 (1995) 7274-7277
8. Chang S.F., Sgro J.Y., and Parrish C.R. Multiple amino acids in the capsid structure of canine parvovirus coordinately determine the canine host range and specific antigenic and hemagglutination properties. J. Virol. 66 12 (1992) 6858-6867
9. Chapman M.S. Structural refinement of the DNA-containing capsid of canine parvovirus using RSRef, a resolution-dependent stereochemically restrained real-space refinement method. Acta Crystallogr., D: Biol. Crystallogr. 52 1 (1996) 129-142
10. Che Z., Olson N.H., Leippe D., Lee W.M., Mosser A.G., Rueckert R.R., Baker T.S., and Smith T.J. Antibody-mediated neutralization of human rhinovirus 14 explored by means of cryoelectron microscopy and X-ray crystallography of virus-Fab complexes. J. Virol. 72 6 (1998) 4610-4622
11. Chen B., Vogan E.M., Gong H., Skehel J.J., Wiley D.C., and Harrison S.C. Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 433 7028 (2005) 834-841
12. Cheng Y., Zak O., Aisen P., Harrison S.C., and Walz T. Structure of the human transferrin receptor-transferrin complex. Cell 116 4 (2004) 565-576
13. Costa A.P., Leite J.P., Labarthe N.V., and Garcia R.C. Genomic typing of canine parvovirus circulating in the state of Rio de Janeiro, Brazil from 1995 to 2001 using polymerase chain reaction assay. Vet. Res. Commun. 29 8 (2005) 735-743
14. Costello F., Steenfos N., Jensen K.T., Christensen J., Gottschalck E., Holm A., and Aasted B. Epitope mapping of Aleutian mink disease parvovirus virion protein VP1 and 2. Scand. J. Immunol. 49 4 (1999) 347-354
15. Domingo E., Verdaguer N., Ochoa W.F., Ruiz-Jarabo C.M., Sevilla N., Baranowski E., Mateu M.G., and Fita I. Biochemical and structural studies with neutralizing antibodies raised against foot-and-mouth disease virus. Virus Res. 62 2 (1999) 169-175
16. Edwards M.J., and Dimmock N.J. A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity. J. Gen. Virol. 82 6 (2001) 1387-1395
17. Edwards M.J., and Dimmock N.J. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event. J. Virol. 75 21 (2001) 10208-10218
18. Elia G., Cavalli A., Cirone F., Lorusso E., Camero M., Buonavoglia D., and Tempesta M. Antibody levels and protection to canine parvovirus type 2. J. Vet. Med. B Infect. Dis. Vet. Public Health 52 7-8 (2005) 320-322
19. Enns C.A. The transferrin receptor. In: Templeton D.M. (Ed). Molecular and Cellular Iron Transport (2002), Marcel Dekker, New York 71-94
20. Fuchs H., Orberger G., Tauber R., and Gessner R. Direct calibration ELISA: a rapid method for the simplified determination of association constants of unlabeled biological molecules. J. Immunol. Methods 188 2 (1995) 197-208
21. Gao G., Alvira M.R., Somanathan S., Lu Y., Vandenberghe L.H., Rux J.J., Calcedo R., Sanmiguel J., Abbas Z., and Wilson J.M. Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc. Natl. Acad. Sci. U.S.A. 100 10 (2003) 6081-6086
22. Giannetti A.M., Snow P.M., Zak O., and Bjorkman P.J. Mechanism for multiple ligand recognition by the human transferrin receptor. PLoS Biol. 1 3 (2003) E51
23. Gomez-Puertas P., Rodriguez F., Oviedo J.M., Ramiro-Ibanez F., Ruiz-Gonzalvo F., Alonso C., and Escribano J.M. Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization. J. Virol. 70 8 (1996) 5689-5694
24. Govindasamy L., Hueffer K., Parrish C.R., and Agbandje-McKenna M. Structures of host range-controlling regions of the capsids of canine and feline parvoviruses and mutants. J. Virol. 77 22 (2003) 12211-12221
25. Hafenstein, S., Rossmann, M.G., Palermo, L.M., Parrish, C.R., 2006. unpublished results.
26. Holguin A., Hernandez J., Martinez M.A., Mateu M.G., and Domingo E. Differential restrictions on antigenic variation among antigenic sites of foot-and-mouth disease virus in the absence of antibody selection. J. Gen. Virol. 78 3 (1997) 601-609
27. Hueffer K., Govindasamy L., Agbandje-McKenna M., and Parrish C.R. Combinations of two capsid regions controlling canine host range determine canine transferrin receptor binding by canine and feline parvoviruses. J. Virol. 77 18 (2003) 10099-10105
28. Hueffer K., Parker J.S., Weichert W.S., Geisel R.E., Sgro J.Y., and Parrish C.R. The natural host range shift and subsequent evolution of canine parvovirus resulted from virus-specific binding to the canine transferrin receptor. J. Virol. 77 3 (2003) 1718-1726
29. Hueffer K., Palermo L.M., and Parrish C.R. Parvovirus infection of cells by using variants of the feline transferrin receptor altering clathrin-mediated endocytosis, membrane domain localization, and capsid-binding domains. J. Virol. 78 11 (2004) 5601-5611
30. Kaufmann B., Simpson A.A., and Rossmann M.G. The structure of human parvovirus B19. Proc. Natl. Acad. Sci. U.S.A. 101 32 (2004) 11628-11633
31. Klasse P.J., and Sattentau Q.J. Occupancy and mechanism in antibody-mediated neutralization of animal viruses. J. Gen. Virol. 83 9 (2002) 2091-2108
32. Knossow M., Gaudier M., Douglas A., Barrere B., Bizebard T., Barbey C., Gigant B., and Skehel J.J. Mechanism of neutralization of influenza virus infectivity by antibodies. Virology 302 2 (2002) 294-298
33. Kwong P.D., Wyatt R., Robinson J., Sweet R.W., Sodroski J., and Hendrickson W.A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393 6686 (1998) 648-659
34. Langeveld J.P., Casal J.I., Vela C., Dalsgaard K., Smale S.H., Puijk W.C., and Meloen R.H. B-cell epitopes of canine parvovirus: distribution on the primary structure and exposure on the viral surface. J. Virol. 67 2 (1993) 765-772
35. Langeveld J.P., Casal J.I., Cortes E., van de Wetering G., Boshuizen R.S., Schaaper W.M., Dalsgaard K., and Meloen R.H. Effective induction of neutralizing antibodies with the amino terminus of VP2 of canine parvovirus as a synthetic peptide. Vaccine 12 15 (1994) 1473-1480
36. Lawrence C.M., Ray S., Babyonyshev M., Galluser R., Borhani D.W., and Harrison S.C. Crystal structure of the ectodomain of human transferrin receptor. Science 286 5440 (1999) 779-782
37. Ledford R.M., Patel N.R., Demenczuk T.M., Watanyar A., Herbertz T., Collett M.S., and Pevear D.C. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds. J. Virol. 78 7 (2004) 3663-3674
38. Liebermann H., Mentel R., Bauer U., Pring-Akerblom P., Dolling R., Modrow S., and Seidel W. Receptor binding sites and antigenic epitopes on the fiber knob of human adenovirus serotype 3. J. Virol. 72 11 (1998) 9121-9130
39. Lopez de Turiso J.A., Cortez E., Ranz A., Garcia J., Sanz A., Vela C., and Casal J.I. Fine mapping of canine parvovirus B cell epitopes. J. Gen. Virol. 72 10 (1991) 2445-2456
40. Ludert J.E., Ruiz M.C., Hidalgo C., and Liprandi F. Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation. J. Virol. 76 13 (2002) 6643-6651
41. Martella V., Cavalli A., Pratelli A., Bozzo G., Camero M., Buonavoglia D., Narcisi D., Tempesta M., and Buonavoglia C. A canine parvovirus mutant is spreading in Italy. J. Clin. Microbiol. 42 3 (2004) 1333-1336
42. Martella V., Cavalli A., Decaro N., Elia G., Desario C., Campolo M., Bozzo G., Tarsitano E., and Buonavoglia C. Immunogenicity of an intranasally administered modified live canine parvovirus type 2b vaccine in pups with maternally derived antibodies. Clin. Diagn. Lab. Immunol. 12 10 (2005) 1243-1245
43. McKenna R., Olson N.H., Chipman P.R., Baker T.S., Booth T.F., Christensen J., Aasted B., Fox J.M., Bloom M.E., Wolfinbarger J.B., and Agbandje-McKenna M. Three-dimensional structure of Aleutian mink disease parvovirus: implications for disease pathogenicity. J. Virol. 73 8 (1999) 6882-6891
44. Meunier P.C., Cooper B.J., Appel M.J., and Slauson D.O. Pathogenesis of canine parvovirus enteritis: the importance of viremia. Vet. Pathol. 22 1 (1985) 60-71
45. Mochizuki M., Harasawa R., and Nakatani H. Antigenic and genomic variabilities among recently prevalent parvoviruses of canine and feline origin in Japan. Vet. Microbiol. 38 1-2 (1993) 1-10
46. Nakamura K., Sakamoto M., Ikeda Y., Sato E., Kawakami K., Miyazawa T., Tohya Y., Takahashi E., Mikami T., and Mochizuki M. Pathogenic potential of canine parvovirus types 2a and 2c in domestic cats. Clin. Diagn. Lab. Immunol. 8 3 (2001) 663-668
47. Nakamura M., Nakamura K., Miyazawa T., Tohya Y., Mochizuki M., and Akashi H. Monoclonal antibodies that distinguish antigenic variants of canine parvovirus. Clin. Diagn. Lab. Immunol. 10 6 (2003) 1085-1089
48. Nakamura M., Tohya Y., Miyazawa T., Mochizuki M., Phung H.T., Nguyen N.H., Huynh L.M., Nguyen L.T., Nguyen P.N., Nguyen P.V., Nguyen N.P., and Akashi H. A novel antigenic variant of canine parvovirus from a Vietnamese dog. Arch. Virol. 149 11 (2004) 2261-2269
49. Nybakken G.E., Oliphant T., Johnson S., Burke S., Diamond M.S., and Fremont D.H. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437 7059 (2005) 764-769
50. Osiowy C., and Anderson R. Neutralization of respiratory syncytial virus after cell attachment. J. Virol. 69 2 (1995) 1271-1274
51. Padron E., Bowman V., Kaludov N., Govindasamy L., Levy H., Nick P., McKenna R., Muzyczka N., Chiorini J.A., Baker T.S., and Agbandje-McKenna M. Structure of adeno-associated virus type 4. J. Virol. 79 8 (2005) 5047-5058
52. Palermo L.M., Hueffer K., and Parrish C.R. Residues in the apical domain of the feline and canine transferrin receptors control host-specific binding and cell infection of canine and feline parvoviruses. J. Virol. 77 16 (2003) 8915-8923
53. Palermo L.M., Hafenstein S.L., and Parrish C.R. Purified feline and canine transferrin receptors reveal complex interactions with the capsids of canine and feline parvoviruses that correspond to their host ranges. J. Virol. 80 17 (2006) 8482-8492
54. Parker J.S.L., Murphy W.J., Wang D., O'Brien S.J., and Parrish C.R. Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells. J. Virol. 75 8 (2001) 3896-3902
55. Parrish C.R. Mapping specific functions in the capsid structure of canine parvovirus and feline panleukopenia virus using infectious plasmid clones. Virology 183 1 (1991) 195-205
56. Parrish C.R., and Carmichael L.E. Antigenic structure and variation of canine parvovirus type-2, feline panleukopenia virus, and mink enteritis virus. Virology 129 2 (1983) 401-414
57. Parrish C.R., Carmichael L.E., and Antczak D.F. Antigenic relationships between canine parvovirus type-2, feline panleukopenia virus and mink enteritis virus using conventional antisera and monoclonal antibodies. Arch. Virol. 72 4 (1982) 267-278
58. Parrish C.R., Gorham J.R., Schwartz T.M., and Carmichael L.E. Characterisation of antigenic variation among mink enteritis virus isolates. Am. J. Vet. Res. 45 12 (1984) 2591-2599
59. Parrish C.R., O'Connell P.H., Evermann J.F., and Carmichael L.E. Natural variation of canine parvovirus. Science 230 4729 (1985) 1046-1048
60. Parrish C.R., Have P., Foreyt W.J., Evermann J.F., Senda M., and Carmichael L.E. The global spread and replacement of canine parvovirus strains. J. Gen. Virol. 69 5 (1988) 1111-1116
61. Parrish C.R., Aquadro C., Strassheim M.L., Evermann J.F., Sgro J.-Y., and Mohammed H. Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus. J. Virol. 65 12 (1991) 6544-6552
62. Pollock R.V.H., and Carmichael L.E. Maternally derived immunity to canine parvovirus infection: transfer, decline and interference with vaccination. J. Am. Vet. Med. Assoc. 180 1 (1982) 37-42
63. Rimmelzwaan G.F., Carlson J., UytdeHaag F.G., and Osterhaus A.D. A synthetic peptide derived from the amino acid sequence of canine parvovirus structural proteins which defines a B cell epitope and elicits antiviral antibody in BALB c mice. J. Gen. Virol. 71 11 (1990) 2741-2745
64. Rossmann M.G., He Y., and Kuhn R.J. Picornavirus-receptor interactions. Trends Microbiol. 10 7 (2002) 324-331
65. Rota J.S., Hummel K.B., Rota P.A., and Bellini W.J. Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology 188 1 (1992) 135-142
66. Rota J.S., Wang Z.D., Rota P.A., and Bellini W.J. Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res. 31 3 (1994) 317-330
67. Sagazio P., Tempesta M., Buonavoglia D., Cirone F., and Buonavoglia C. Antigenic characterization of canine parvovirus strains isolated in Italy. J. Virol. Methods 73 2 (1998) 197-200
68. Saphire E.O., Parren P.W., Pantophlet R., Zwick M.B., Morris G.M., Rudd P.M., Dwek R.A., Stanfield R.L., Burton D.R., and Wilson I.A. Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. Science 293 5532 (2001) 1155-1159
69. Sheshberadaran H., and Norrby E. Characterization of epitopes on the measles virus hemagglutinin. Virology 152 1 (1986) 58-65
70. Sheshberadaran H., Norrby E., and Rammohan K.W. Monoclonal antibodies against five structural components of measles virus. II. Characterization of five cell lines persistently infected with measles virus. Arch. Virol. 83 3-4 (1985) 251-268
71. Simpson A.A., Chipman P.R., Baker T.S., Tijssen P., and Rossmann M.G. The structure of an insect parvovirus (Galleria mellonella Densovirus) at 3.7 Å resolution. Structure 6 11 (1998) 1355-1367
72. Skehel J.J., and Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69 (2000) 531-569
73. Smith T.J., Chase E.S., Schmidt T.J., Olson N.H., and Baker T.S. Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon. Nature 383 6598 (1996) 350-354
74. Steinel A., Venter E.H., Van Vuuren M., Parrish C.R., and Truyen U. Antigenic and genetic analysis of canine parvoviruses in southern Africa. Onderstepoort J. Vet. Res. 65 4 (1998) 239-242
75. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., and Fouchier R.A. Mapping the antigenic and genetic evolution of influenza virus. Science 305 5682 (2004) 371-376
76. Strassheim L.S., Gruenberg A., Veijalainen P., Sgro J.-Y., and Parrish C.R. Two dominant neutralizing antigenic determinants of canine parvovirus are found on the threefold spike of the virus capsid. Virology 198 1 (1994) 175-184
77. Truyen U., and Parrish C.R. Canine and feline host ranges of canine parvovirus and feline panleukopenia virus: distinct host cell tropisms of each virus in vitro and in vivo. J. Virol. 66 9 (1992) 5399-5408
78. Truyen U., Gruenberg A., Chang S.F., Obermaier B., Veijalainen P., and Parrish C.R. Evolution of the feline-subgroup parvoviruses and the control of canine host range in vivo. J. Virol. 69 8 (1995) 4702-4710
79. Truyen U., Evermann J.F., Vieler E., and Parrish C.R. Evolution of canine parvovirus involved loss and gain of feline host range. Virology 215 2 (1996) 186-189
80. Tsao J., Chapman M.S., Agbandje M., Keller W., Smith K., Wu H., Luo M., Smith T.J., Rossmann M.G., Compans R.W., and Parrish C.R. The three-dimensional structure of canine parvovirus and its functional implications. Science 251 5000 (1991) 1456-1464
81. Varghese R., Mikyas Y., Stewart P.L., and Ralston R. Postentry neutralization of adenovirus type 5 by an antihexon antibody. J. Virol. 78 22 (2004) 12320-12332
82. Verdaguer N., Schoehn G., Ochoa W.F., Fita I., Brookes S., King A., Domingo E., Mateu M.G., Stuart D., and Hewat E.A. Flexibility of the major antigenic loop of foot-and-mouth disease virus bound to a Fab fragment of a neutralising antibody: structure and neutralisation. Virology 255 2 (1999) 260-268
83. Vossen M.T., Westerhout E.M., Soderberg-Naucler C., and Wiertz E.J. Viral immune evasion: a masterpiece of evolution. Immunogenetics 54 8 (2002) 527-542
84. Walters R.W., Agbandje-McKenna M., Bowman V.D., Moninger T.O., Olson N.H., Seiler M., Chiorini J.A., Baker T.S., and Zabner J. Structure of adeno-associated virus serotype 5. J. Virol. 78 7 (2004) 3361-3371
85. Waner T., Naveh A., Wudovsky I., and Carmichael L.E. Assessment of maternal antibody decay and response to canine parvovirus vaccination using a clinic-based enzyme-linked immunosorbent assay. J. Vet. Diagn. Invest. 8 4 (1996) 427-432
86. Weichert W.S., Parker J.S., Wahid A.T.M., Chang S.F., Meier E., and Parrish C.R. Assaying for structural variation in the parvovirus capsid and its role in infection. Virology 250 1 (1998) 106-117
87. West Jr. A.P., Giannetti A.M., Herr A.B., Bennett M.J., Nangiana J.S., Pierce J.R., Weiner L.P., Snow P.M., and Bjorkman P.J. Mutational analysis of the transferrin receptor reveals overlapping HFE and transferrin binding sites. J. Mol. Biol. 313 2 (2001) 385-397
88. Wikoff W.R., Wang G., Parrish C.R., Cheng R.H., Strassheim M.L., Baker T.S., and Rossmann M.G. The structure of a neutralized virus: canine parvovirus complexed with neutralizing antibody fragment. Structure 2 7 (1994) 595-607
89. Wobus C.E., Hugle-Dorr B., Girod A., Petersen G., Hallek M., and Kleinschmidt J.A. Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. J. Virol. 74 19 (2000) 9281-9293
90. Xie Q., and Chapman M.S. Canine parvovirus capsid structure, analyzed at 2.9 Å resolution. J. Mol. Biol. 264 3 (1996) 497-520
91. Xie Q., Bu W., Bhatia S., Hare J., Somasundaram T., Azzi A., and Chapman M.S. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc. Natl. Acad. Sci. U. S. A. 99 16 (2002) 10405-10410
92. Yuan W., and Parrish C.R. Comparison of two single-chain antibodies that neutralize canine parvovirus: analysis of an antibody-combining site and mechanisms of neutralization. Virology 269 2 (2000) 471-480